| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3877601 | The Journal of Urology | 2005 | 5 Pages |
Abstract
SRT results in durable prostate specific antigen control in select patients. It is well tolerated with few severe late effects. Increasing Gleason score, lymphovascular invasion and lack of a complete response to SRT are significant risks for disease progression requiring additional management.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
JOSEPH P. BROOKS, PAUL S. ALBERT, RICHARD B. WILDER, DEAN A. GANT, DAVID G. McLEOD, MATTHEW M. POGGI,